Exhibit 4.4
ZI TOPRUN ACQUISITION CORP.
WARRANT AGREEMENT
THIS WARRANT AGREEMENT (this “Agreement”), dated as of __________ __, 2022, is by and between Zi Toprun Acquisition Corp., a Delaware corporation (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation with offices at 1 State Street, New York, New York 10004, as warrant agent (the “Warrant Agent” or also referred to herein as the “Transfer Agent”).
WHEREAS, the Company intends to effect an initial public offering (the “Offering”) of 11,000,000 units (“Units”) of the Company’s equity securities, each such unit comprised of (i) one share of common stock of the Company, of par value $0.00001 per share (“Common Stock”) and (ii) one redeemable Public Warrant (as defined below), which number of Units may be increased by the exercise by the underwriters of its over-allotment option by up to an additional 1,650,000 Units; and
WHEREAS, as part of the Offering, the Company will issue and deliver up to 11,000,000 warrants (or up to 12,650,000 warrants if the Over-allotment Option (as defined below) is exercised in full) to public investors in the Offering (the “Public Warrants”); and
WHEREAS, each whole Public Warrant entitles the holder thereof to purchase one share of Common Stock for $11.50 per whole share, subject to adjustment as described herein; and
WHEREAS, on __________, 2022, the Company has entered into that certain Private Placement Units Purchase Agreement with Toprun Smart Management LLC, a Delaware limited liability company (the “Sponsor”), pursuant to which the Sponsor agreed to purchase an aggregate of 450,000 private placement units (or up to 499,500 private placement units if the underwriters in the Offering exercise their Over-allotment Option in full) simultaneously with the closing of the Offering (and the closing of the Over-allotment Option, if applicable) (the “Private Units”) at a price of $10.00 per unit, and, in connection therewith, up to an aggregate of 450,000 warrants (or 499,500 warrants if the Over-allotment Option is exercise in full) underlying such Private Units (the “Private Warrants”), each Private Warrant entitling the holder thereof to purchase one share of Common Stock for $11.50 per whole share;
WHEREAS, in order to finance the Company’s transaction costs in connection with an intended initial Business Combination (as defined below), the Sponsor or an affiliate of the Sponsor or certain of the Company’s executive officers and directors may, but are not obligated to, loan to the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible into up to an additional 150,000 units (the “Working Capital Units”), each Working Capital Unit comprised of one share of Common Stock and one warrant (the “Working Capital Warrant”), each Working Capital Warrant entitling the holder thereof to purchase one share of Common Stock for $11.50 per whole share, at a price of $10.00 per Working Capital Unit; and
WHEREAS, following consummation of the Offering, the Sponsor or its designees and affiliates may provide up to $3,300,000 ($3,795,000 if the underwriters exercise their Over-allotment Option in full) to the Company in the form of a loan in the event that the Company extends the time period within which it must consummate a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities (“Business Combination”), which loan may be convertible into an additional 330,000 units (or up to 379,500 units if the underwriters’ over-allotment option is exercised) (“Extension Units”), each Extension Unit comprised of one share of Common Stock and one warrant (the “Extension Warrants”), each Extension Warrant entitling the holder thereof to purchase one share of Common Stock for $11.50 per whole share, at a price of $10.00 per Extension Unit; and
WHEREAS, following consummation of the Offering, the Company may issue additional warrants to purchase shares of Common Stock (“Post IPO Warrants”; together with the Public Warrants, the Private Warrants, the Working Capital Warrants, and the Extension Warrants, collectively the “Warrants”) in connection with, or following the consummation by the Company of a Business Combination (defined below); and
WHEREAS, the Company has filed with the Securities and Exchange Commission (the “Commission”) a registration statement on Form S-1, File No. 333-264430 (the “Registration Statement”) and prospectus (the “Prospectus”), for the registration for offer and sale, under the Securities Act of 1933, as amended (the “Securities Act”), of the Units, the Public Warrants, the Common Stock included in the Units and the Common Stock underlying the Public Warrants, and which Registration Statement has been declared effective by the Commission on ________, 2022; and
{N0382172 2 }